Pimozide 2mg/day (current) or 4 mg/day (study initiation) ( DrugBank: Pimozide )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	1

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03272503 (ClinicalTrials.gov)	October 27, 2017	31/8/2017	A Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis (ALS)	A Phase II Randomized, Placebo-Controlled, Double Blinded, Multi-Centre Clinical Trial of Pimozide i ...	ALS;Amyotrophic Lateral Sclerosis	Drug: Pimozide 2mg/day (current) or 4 mg/day (study initiation);Drug: Placebo Oral Tablet	University of Calgary	ALS Canada;Brain Canada	Recruiting	18 Years	N/A	All	100	Phase 2	Canada

First Previous1Next Last